Search - tctmd.com

Displaying 261 - 280 of 456

Sort: Relevancy | Date

News Features

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Yael L. Maxwell

January 12, 2018

Podcast

Complete Revascularization, Bioresorbable Stents, and More

January 10, 2018

News Daily News

De-escalating DAPT to a Clopidogrel-Based Strategy After PCI for ACS Gets Boost in TOPIC-VASP

Yael L. Maxwell

January 04, 2018

News Daily News

Higher Bleeding Risks, Radial Advantages Confirmed in Women With ACS Undergoing PCI: MATRIX Subanalysis

Yael L. Maxwell

January 03, 2018

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2017

Shelley Wood

December 28, 2017

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Industry News

Oceanus 14 Pro, PTA balloon catheter receives CE Mark Approval

December 20, 2017

News Daily News

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

Michael O'Riordan

December 14, 2017

News Daily News

FDA Approves EluNIR Drug-Eluting Stent

Michael O'Riordan

November 30, 2017

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Conference News TCT 2017

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Michael O'Riordan

November 01, 2017

Presentation TCT 2017

Is There a Preferred Stent for the Diabetic Patient?

Presenter: David J. Maron, Alan C. Yeung, Upendra Kaul

November 01, 2017

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

Podcast TCTMD Talking Points

COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting

October 18, 2017

Presentation

Mid- and Long-term Outcome Comparisons of Absorb BVS vs Everolimus-Eluting Stent

October 17, 2017

Advertisement

Cardiologists Treating Syrian Refugees Call Missions an ‘Addictive’ Passion That Saves Lives

Complete Revascularization, Bioresorbable Stents, and More

De-escalating DAPT to a Clopidogrel-Based Strategy After PCI for ACS Gets Boost in TOPIC-VASP

Higher Bleeding Risks, Radial Advantages Confirmed in Women With ACS Undergoing PCI: MATRIX Subanalysis

TCTMD’s Top 10 Most Popular Stories for December 2017

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Oceanus 14 Pro, PTA balloon catheter receives CE Mark Approval

PCI Comparable to CABG in Left Main Coronary Disease: Meta-analysis

FDA Approves EluNIR Drug-Eluting Stent

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

DES With Bioresorbable Polymer Outperforms BMS in SENIOR Patients

Is There a Preferred Stent for the Diabetic Patient?

Long-term Absorb BVS Data Continue to Disappoint

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

TCTMD’s Top 10 Most Popular Stories for October 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

COLOR - A Multicenter Registry Looking at Lipid-Rich Plaque and 2-Year Outcomes After Stenting

Mid- and Long-term Outcome Comparisons of Absorb BVS vs Everolimus-Eluting Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content